Evaluating the impact of prescription drug monitoring program implementation: a scoping review
Abstract Background Prescription drug monitoring programs (PDMPs) have been implemented in 49 out of 50 states in an effort to reduce opioid-related misuse, abuse, and mortality, yet the literature evaluating the impact of PDMP implementation remains limited. We conducted a scoping review to: (1) de...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2017-06-01
|
| Series: | BMC Health Services Research |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12913-017-2354-5 |
| _version_ | 1818525258503684096 |
|---|---|
| author | Erin P. Finley Ashley Garcia Kristen Rosen Don McGeary Mary Jo Pugh Jennifer Sharpe Potter |
| author_facet | Erin P. Finley Ashley Garcia Kristen Rosen Don McGeary Mary Jo Pugh Jennifer Sharpe Potter |
| author_sort | Erin P. Finley |
| collection | DOAJ |
| description | Abstract Background Prescription drug monitoring programs (PDMPs) have been implemented in 49 out of 50 states in an effort to reduce opioid-related misuse, abuse, and mortality, yet the literature evaluating the impact of PDMP implementation remains limited. We conducted a scoping review to: (1) describe available evidence regarding impact of PDMPs in the U.S.; and (2) propose a conceptual model to inform future PDMP implementation and evaluation efforts. Methods Scoping systematic review following Arksey and O’Malley’s (2005) methodology. We identified 11 relevant studies based on inclusion criteria using a PubMed database search of English-language studies published 1/1/2000–5/31/16. Data were extracted and thematic analysis conducted to synthesize results. Results Extant evidence for the impact of PDMPs as an opioid risk mitigation tool remains mixed. Thematic analysis revealed four domains of opioid-related outcomes frequently examined in original studies evaluating PDMP implementation: (1) opioid prescribing; (2) opioid diversion and supply; (3) opioid misuse; and (4) opioid-related morbidity and mortality. An evaluation framework incorporating these domains is presented that highlights significant gaps in empirical research across each of these domains. Conclusions Evidence for the impact of state-level PDMPs remains mixed. We propose a conceptual model for evaluating PDMP implementation toward the goals of clarifying PDMP mechanisms of impact, identifying characteristics of PDMPs associated with best outcomes, and maximizing the utility of PDMP policy and implementation to reduce opioid-related public health burden. |
| first_indexed | 2024-12-11T06:07:05Z |
| format | Article |
| id | doaj.art-a6bf82846c9046bdb39e995c00b636e2 |
| institution | Directory Open Access Journal |
| issn | 1472-6963 |
| language | English |
| last_indexed | 2024-12-11T06:07:05Z |
| publishDate | 2017-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Health Services Research |
| spelling | doaj.art-a6bf82846c9046bdb39e995c00b636e22022-12-22T01:18:16ZengBMCBMC Health Services Research1472-69632017-06-011711810.1186/s12913-017-2354-5Evaluating the impact of prescription drug monitoring program implementation: a scoping reviewErin P. Finley0Ashley Garcia1Kristen Rosen2Don McGeary3Mary Jo Pugh4Jennifer Sharpe Potter5University of Texas Health Science Center San AntonioUniversity of Texas Health Science Center San AntonioUniversity of Texas Health Science Center San AntonioUniversity of Texas Health Science Center San AntonioUniversity of Texas Health Science Center San AntonioUniversity of Texas Health Science Center San AntonioAbstract Background Prescription drug monitoring programs (PDMPs) have been implemented in 49 out of 50 states in an effort to reduce opioid-related misuse, abuse, and mortality, yet the literature evaluating the impact of PDMP implementation remains limited. We conducted a scoping review to: (1) describe available evidence regarding impact of PDMPs in the U.S.; and (2) propose a conceptual model to inform future PDMP implementation and evaluation efforts. Methods Scoping systematic review following Arksey and O’Malley’s (2005) methodology. We identified 11 relevant studies based on inclusion criteria using a PubMed database search of English-language studies published 1/1/2000–5/31/16. Data were extracted and thematic analysis conducted to synthesize results. Results Extant evidence for the impact of PDMPs as an opioid risk mitigation tool remains mixed. Thematic analysis revealed four domains of opioid-related outcomes frequently examined in original studies evaluating PDMP implementation: (1) opioid prescribing; (2) opioid diversion and supply; (3) opioid misuse; and (4) opioid-related morbidity and mortality. An evaluation framework incorporating these domains is presented that highlights significant gaps in empirical research across each of these domains. Conclusions Evidence for the impact of state-level PDMPs remains mixed. We propose a conceptual model for evaluating PDMP implementation toward the goals of clarifying PDMP mechanisms of impact, identifying characteristics of PDMPs associated with best outcomes, and maximizing the utility of PDMP policy and implementation to reduce opioid-related public health burden.http://link.springer.com/article/10.1186/s12913-017-2354-5Prescription Monitoring ProgramOpioid Risk MitigationScoping ReviewEvaluationHealth policy |
| spellingShingle | Erin P. Finley Ashley Garcia Kristen Rosen Don McGeary Mary Jo Pugh Jennifer Sharpe Potter Evaluating the impact of prescription drug monitoring program implementation: a scoping review BMC Health Services Research Prescription Monitoring Program Opioid Risk Mitigation Scoping Review Evaluation Health policy |
| title | Evaluating the impact of prescription drug monitoring program implementation: a scoping review |
| title_full | Evaluating the impact of prescription drug monitoring program implementation: a scoping review |
| title_fullStr | Evaluating the impact of prescription drug monitoring program implementation: a scoping review |
| title_full_unstemmed | Evaluating the impact of prescription drug monitoring program implementation: a scoping review |
| title_short | Evaluating the impact of prescription drug monitoring program implementation: a scoping review |
| title_sort | evaluating the impact of prescription drug monitoring program implementation a scoping review |
| topic | Prescription Monitoring Program Opioid Risk Mitigation Scoping Review Evaluation Health policy |
| url | http://link.springer.com/article/10.1186/s12913-017-2354-5 |
| work_keys_str_mv | AT erinpfinley evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview AT ashleygarcia evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview AT kristenrosen evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview AT donmcgeary evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview AT maryjopugh evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview AT jennifersharpepotter evaluatingtheimpactofprescriptiondrugmonitoringprogramimplementationascopingreview |